(Q34190097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

review article

1 reference

title

Varenicline for tobacco dependence: panacea or plight? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Jill M Williams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Michael B Steinberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Marc L Steinberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Kunal K Gandhi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Rajiv Ulpe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

6 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

1799-1812

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study

3 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Nicotine receptor partial agonists for smoking cessation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

A preliminary investigation of varenicline for heavy drinking smokers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Increased risk of suicidal ideation in smokers and former smokers compared to never smokers: evidence from the Baltimore ECA follow-up study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

A pilot study to assess smokeless tobacco use reduction with varenicline

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Thoughts and acts of aggression/violence toward others reported in association with varenicline

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Smoking outcome by psychiatric history after behavioral and varenicline treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Visual hallucinations associated with varenicline: a case report

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline augmentation in depressed smokers: an 8-week, open-label study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline reduces alcohol self-administration in heavy-drinking smokers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline improves mood and cognition during smoking abstinence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline treatment for smokers with schizophrenia: a case series.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline may trigger severe hypoglycaemia in Type 1 diabetes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Tobacco use among those with serious psychological distress: results from the national survey of drug use and health, 2002

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Sex Differences in Clinical Predictors of Suicidal Acts After Major Depression: A Prospective Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Effectiveness of smoking cessation therapies: a systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Cytisine for smoking cessation: a literature review and a meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

FDA speeds smoking cessation drug review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Smoking and the risk of suicidal behavior: a prospective study of a community sample

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Smoking and mental illness: A population-based prevalence study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation

5 July 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

The need for dissemination of evidence-based results from research on nicotine and tobacco

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Efficacy of varenicline for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Varenicline and smokers with mental illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Characteristics and smoking cessation outcomes of patients returning for repeat tobacco dependence treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Studies linking smoking-cessation drug with suicide risk spark concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Exacerbation of recurrent depression as a result of treatment with varenicline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Hypomania with agitation associated with varenicline use in bipolar II disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Varenicline-associated acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Acute generalized exanthematous pustulosis caused by varenicline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Varenicline efficacy and tolerability in a subject with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Successful smoking cessation and improvement of negative symptoms with varenicline in a stable schizophrenia patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Do the 10 UK suicides among those taking the smoking cessation drug varenicline suggest a causal link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

A double-blind study evaluating the long-term safety of varenicline for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Combination treatment with varenicline and nicotine replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

Smoking cessation interventions offered to French adult light smokers: a heterogeneous population with specific needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.587121

A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Chantix-induced mental status changes in a young healthy female.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

The pharmacokinetic and tolerability profile of varenicline in healthy Chinese volunteers.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Nicotine and cotinine levels in body fluids of smokers who committed suicide.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Measures of abstinence in clinical trials: issues and recommendations

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132819

Exacerbation of schizophrenia by varenicline

28 October 2018

1 reference

12 December 2020

Varenicline-induced manic episode in a patient with bipolar disorder

1 reference

12 December 2020

Update on JAMA-EXPRESS: rapid review and publication

1 reference

12 December 2020

The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder

1 reference

12 December 2020

The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial

1 reference

12 December 2020

10.1517/14656566.2011.587121

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21644843%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

PubMed publication ID

21644843

1 reference